...
首页> 外文期刊>The Journal of Experomental Medicine >THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR
【24h】

THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR

机译:血清C'1酯酶抑制剂对血浆,血浆激肽释放酶,血浆通透性因子和补充成分的C'1r成分的抑制作用

获取原文

摘要

The fraction of human serum designated as C'1 esterase inhibitor is known to inhibit the action of C'1 esterase, a plasma kallikrein, and PF/Dil, an enzyme in plasma enhancing cutaneous vascular permeability. In the present study, C'1 esterase inhibitor has been found to block the actions of plasmin and the C'1r subcomponent of the first component of complement, and to retard the generation of PF/Dil. No inhibition of blood clotting or of the generation of plasmin was demonstrable.
机译:已知人类血清中称为C'1酯酶抑制剂的部分可抑制C'1酯酶,血浆激肽释放酶和PF / Dil(血浆中增强皮肤血管通透性的酶)的作用。在本研究中,已发现C'1酯酶抑制剂可阻断纤溶酶和补体第一个成分的C'1r亚成分的作用,并阻止PF / Dil的产生。没有显示出对凝血或纤溶酶产生的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号